Patents Assigned to Bioiberica, S.A.
  • Patent number: 10729728
    Abstract: The present invention refers to a process for preparing an animal brain extract. It also refers to the brain extract obtainable according to said process and to the use thereof as a medicine, in particular for the prevention and/or treatment of neurodegenerative diseases and disorders of the central nervous system. It also refers to compositions comprising this extract and to its use for preparing these compositions.
    Type: Grant
    Filed: April 25, 2016
    Date of Patent: August 4, 2020
    Assignee: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Pere Dalmau Castañares, Ramon Ruhi Roura, Joaquima Guix Salichs, Josep Ribas Maynou, Artur Alfocea Egüén, Antonio Garcia Pedrosa, Purificación Morales García, Pere Leon Martín, Marta Badias Eroles
  • Publication number: 20190192553
    Abstract: The present invention relates to a composition comprising hyaluronic acid, dermatan sulfate, at least one omega-3 fatty acid, and at least one nucleotide. It also relates to the new composition for use in the treatment or prevention of diseases, ailments, dysfunctions, or alterations of the skin, preferably atopic dermatitis. The composition may be in the form of a pharmaceutical composition, food supplement, functional food, or medical food.
    Type: Application
    Filed: April 12, 2017
    Publication date: June 27, 2019
    Applicant: BIOIBERICA, S.A.U.
    Inventors: José ESCAICH FERRER, Sergi SEGARRA LÓPEZ, Javier CÓRDOBA LUCIO, Jorge FLORES GARCÍA, Alfonso VELASCO FRANCO
  • Publication number: 20180140638
    Abstract: The present invention refers to a process for preparing an animal brain extract. It also refers to the brain extract obtainable according to said process and to the use thereof as a medicine, in particular for the prevention and/or treatment of neurodegenerative diseases and disorders of the central nervous system. It also refers to compositions comprising this extract and to its use for preparing these compositions.
    Type: Application
    Filed: April 25, 2016
    Publication date: May 24, 2018
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep ESCAICH FERRER, Daniel MARTINEZ PUIG, Pere DALMAU CASTAÑARES, Ramon RUHI ROURA, Joaquima GUIX SALICHS, Josep RIBAS MAYNOU, Artur ALFOCEA EGÜÉN, Antonio GARCIA PEDROSA, Purificación MORALES GARCÍA, Pere LEON MARTÍN, Marta BADIAS EROLES
  • Patent number: 9687525
    Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: June 27, 2017
    Assignee: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
  • Patent number: 9420785
    Abstract: The present invention is related to the use of compositions comprising an enzymatic hydrolysate of animal cartilage protein, at least one organic acid from an alcoholic fermentation, and water, as attractant for flies of the species Drosophila suzukii. Preferably, the animal cartilage is bovine and/or porcine cartilage and the organic acid from an alcoholic fermentation is wine vinegar, apple cider vinegar, white vinegar or rice vinegar.
    Type: Grant
    Filed: June 12, 2015
    Date of Patent: August 23, 2016
    Assignee: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Anna Botta Català, Manuel Carrión Rodriguez, Cándido Marín Garrido, Núria Sierras Serra, Rafael Piñol Dastis
  • Publication number: 20160228508
    Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.
    Type: Application
    Filed: April 20, 2016
    Publication date: August 11, 2016
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep ESCAICH FERRER, Pere DALMAU CASTANARES, Ana Maria TORRENT GIBERT, Ramon RUHI ROURA, Carlos Raul ALAEZ VERSON
  • Patent number: 9347081
    Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.
    Type: Grant
    Filed: April 16, 2012
    Date of Patent: May 24, 2016
    Assignee: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
  • Publication number: 20160032386
    Abstract: A method for predicting the severity or progression of OA in a human subject, comprising: determining the identity of at least one allele at each of at least 4 positions of single nucleotide polymorphism (SNPs) selected from the group consisting of: rs2206593, rs10465850, rs780094, rs1374281, rs1143634, rs2073508, rs2243250, rs4720262, rs917760, rs7838918, rs12009, rs730720, rs874692, rs893953, rs1799750, rs10845493, rs11054704, rs7986347, rs1802536, rs10519263, rs7342880, rs16947882 and rs10413815, and one or more SNPs in linkage disequilibrium at a level of at least R2?0.8 therewith, as well as products, in particular systems and kits for use in such a method.
    Type: Application
    Filed: January 30, 2014
    Publication date: February 4, 2016
    Applicants: BIOIBERICA, S.A., PROGENIKA BIOPHARMA S.A.
    Inventors: Josep Escaich, Josep Vergés, Ruth Alonso, Eulàlia Montell, Helena Martínez, Marta Herrero, Francisco Blanco, Antonio Martínez, Diego Tejedor, Marta Artieda, Nerea Bartolomé
  • Publication number: 20150366194
    Abstract: The present invention is related to the use of compositions comprising an enzymatic hydrolysate of animal cartilage protein, at least one organic acid from an alcoholic fermentation, and water, as attractant for flies of the species Drosophila suzukii. Preferably, the animal cartilage is bovine and/or porcine cartilage and the organic acid from an alcoholic fermentation is wine vinegar, apple cider vinegar, white vinegar or rice vinegar.
    Type: Application
    Filed: June 12, 2015
    Publication date: December 24, 2015
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep ESCAICH FERRER, Anna BOTTA CATALÀ, Manuel CARRIÓN RODRIGUEZ, Cándido MARÍN GARRIDO, Núria SIERRAS SERRA, Rafael PIÑOL DASTIS
  • Patent number: 9161979
    Abstract: The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: October 20, 2015
    Assignee: Bioiberica, S.A.
    Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Carles Chetrit Russi, Elisabet Borda Casas, Ken-ichi Kosuna
  • Publication number: 20150182597
    Abstract: The present invention relates to a composition comprising hyaluronic acid and dermatan sulphate for use in the treatment or prevention of overweight, obesity, insulin resistance, type 2 diabetes, fatty liver or dyslipidemia or for use in reducing food intake, inducing the feeling of satiety, reducing appetite, reducing body weight, preventing weight gain, reducing body fat, reducing fat formation, reducing blood cholesterol, maintaining normal blood cholesterol levels, reducing blood triglycerides, maintaining normal blood triglyceride levels or increasing insulin sensitivity. The composition can further contain collagen hydrolysate. The composition can be in the form of a pharmaceutical composition, a food, a functional food, a medical food or a food supplement.
    Type: Application
    Filed: July 22, 2013
    Publication date: July 2, 2015
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Ma Luisa Bonet Pina, Daniel Martinez Puig, Nuria Granados Borbolla, Barbara Reynes Miralles, Carles Chetrit Russi, Andreu Palou Oliver
  • Patent number: 8785416
    Abstract: The present invention relates to the use of a series of sulphated disaccharides for the preparation of a medicament for the treatment or prevention of a neurodegenerative and/or neurovascular disease, of a traumatic brain injury or of a traumatic spinal cord injury. The present invention also relates to the use of said sulphated disaccharides for the preparation of a neuroprotective medicament or of an antioxidant medicament. The neurodegenerative and/or neurovascular diseases are preferably: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: July 22, 2014
    Assignees: Bioiberica, S.A., Universidad Autonoma de Madrid
    Inventors: Josep Verges Milano, Antonio Garcia Garcia, Ramon Ruhi Roura, Eulalia Montell Bonaventura, Manuela Garcia Lopez, Carlos Raul Alaez Verson, Josep Escaich Ferrer, Javier Egea Maiquez, Pilar Negredo Madrigal, Silvia Lorrio Gonzalez
  • Publication number: 20140113861
    Abstract: The present invention relates to a method for preparing a cartilage product comprising a protein hydrolysate with a degree of hydrolysis comprised between 0.5% and 3.0%, at least one glycosaminoglycan and at least one growth factor. The present invention also relates to the cartilage product obtainable through said method. Said cartilage product is useful in the treatment or prevention of wounds, ulcers, burns, psoriasis, osteoarthritis, synovitis, osteoporosis, osteopenia, diseases of the tendons and ligaments, periodontal diseases, signs of skin aging, the harmful effects of ultraviolet radiation exposure or stretch marks.
    Type: Application
    Filed: April 16, 2012
    Publication date: April 24, 2014
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Pere Dalmau Castanares, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
  • Publication number: 20130263294
    Abstract: A method for predicting risk of joint dysplasia, osteoarthritis and/or a condition that is secondary to joint dysplasia in a mammalian subject of the order Carnivora, the method comprising: (a) determining the genotype of said subject in respect of one or more genetic polymorphisms and/or alterations, such as polymorphisms in the CHST3 gene; and (b) providing a prediction of said risk based on said genotype. Products for use in such a method and related methods of determining propensity of a subject to respond to therapy and of selective breeding, are also disclosed.
    Type: Application
    Filed: September 19, 2011
    Publication date: October 3, 2013
    Applicants: BIOIBERICA, S.A., PROGENIKA BIOPHARMA, S.A.
    Inventors: Antonio Martinez, Laureano Simon, Diego Tejedor, Marta Artieda, Nerea Bartolome, Jose Escaich, Alfonso Velasco, Miriam Selles, Carlos Chetrit, Daniel Martinez, Armand Sanchez, Olga Francino, Elisenda Sanchez
  • Patent number: 8445462
    Abstract: The present invention relates to compositions comprising chondroitin sulphate and mannosamine or a derivative thereof. The mannosamine derivative is preferably N-acetylmannosamine. The compositions may comprise glucosamine. Said compositions are useful in the treatment or prevention of degenerative joint diseases, preferably of osteoarthritis, in the treatment or prevention of tendon or ligament diseases, disorders or injuries and of immune system diseases, preferably of rheumatoid arthritis.
    Type: Grant
    Filed: December 17, 2008
    Date of Patent: May 21, 2013
    Assignee: Bioiberica, S.A.
    Inventors: Josep Escaich Ferrer, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Pere Dalmau Castanares
  • Patent number: 8394781
    Abstract: Disaccharides for the treatment of tendons, ligaments and bones. The present invention relates to the use of a series of disaccharides, as well as of compositions containing them, for the preparation of a medicament for the treatment or prevention of a tendon, ligament or bone disease, disorder or injury. The present invention also relates to the new compositions comprising a disaccharide in combination with inulin polysulphate, a glycosaminoglycan, a growth factor or cells. The glycosaminoglycan is preferably chondroitin sulphate or hyaluronic acid and the growth factor is IFG-1.
    Type: Grant
    Filed: May 15, 2008
    Date of Patent: March 12, 2013
    Assignee: Bioiberica, S.A.
    Inventors: Josep Escaich Ferrer, Ana Maria Torrent Gibert, Ramon Ruhi Roura, Carlos Raul Alaez Verson
  • Publication number: 20120309707
    Abstract: The present invention relates to the use of a series of sulphated disaccharides for the preparation of a medicament for the treatment or prevention of a neurodegenerative and/or neurovascular disease, of a traumatic brain injury or of a traumatic spinal cord injury. The present invention also relates to the use of said sulphated disaccharides for the preparation of a neuroprotective medicament or of an antioxidant medicament. The neurodegenerative and/or neurovascular diseases are preferably: Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and stroke.
    Type: Application
    Filed: December 22, 2010
    Publication date: December 6, 2012
    Applicants: UNIVERSIDAD AUTONOMA DE MADRID, BIOIBERICA, S.A.
    Inventors: Josep Verges Milano, Antonio Garcia Garcia, Ramon Ruhi Roura, Eulalia Montell Bonaventura, Manuela Garcia Lopez, Carlos Raul Alaez Verson, Josep Escaich Ferrer, Javier Egea Maiquez, Pilar Negredo Madrigal, Silvia Lorrio Gonzalez
  • Patent number: 8296073
    Abstract: A method for prognosing osteoporosis phenotypes or estimating osteoporosis quantitative traits comprising determining outcomes for selected SNP variables and clinical variables. Products and methods for genotyping multiple osteoporosis associated genetic variations.
    Type: Grant
    Filed: July 12, 2007
    Date of Patent: October 23, 2012
    Assignees: Progenika Biopharma, S.A., Bioiberica, S.A.
    Inventors: Ainara Cadaval, Diego Tejedor Hernández, Antonio Martínez Martínez, Laureano Simón Buela
  • Publication number: 20110213020
    Abstract: The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions include Nucleoforce® or Nucleoforce® Dogs and AHCC®. Said compositions are useful in the treatment and prevention of immunosuppression, of the toxicity derived from chemotherapy or radiotherapy treatment, of diseases of the immune system, of cancer or an infection; and are also useful to stimulate the immune function in a mammal, including a human.
    Type: Application
    Filed: September 8, 2009
    Publication date: September 1, 2011
    Applicant: BIOIBERICA, S.A.
    Inventors: Josep Escaich Ferrer, Daniel Martinez Puig, Carles Chetrit Russi, Elisabet Borda Casas, Ken-ichi Kosuna
  • Patent number: 7943598
    Abstract: The present invention relates to the use of an organic glucosamine salt selected from glucosamine glucuronate, glucosamine ascorbate, glucosamine malate, glucosamine hydrogen malate, glucosamine citrate, glucosamine hydrogen citrate, and glucosamine dihydrogen citrate for the preparation of a medicament for the treatment of arthrosis and inflammation and pain associated with arthrosis. The present invention also relates to the use of an organic glucosamine salt, selected from the ones mentioned above, for the preparation of a nutritional supplement acting as a chondroprotector, to nourish the cartilage, protect the joints, prevent water deficit in the tissues that form the joint, improve the joints' functional capacity, elasticity, and flexibility, and prevent and revert the physical overexertion syndrome in athletes, and the effects associated therewith.
    Type: Grant
    Filed: June 23, 2005
    Date of Patent: May 17, 2011
    Assignee: Bioiberica, S.A.
    Inventors: Josep Escaich Ferrer, Ramon Ruhi Roura, Ana Maria Torrent Gibert